In yesterday’s Wall Street session, Ovid Therapeutics Inc (NASDAQ:OVID) shares traded at $0.79, down -0.22% from the previous session.
OVID stock price is now -74.39% away from the 50-day moving average and -76.35% away from the 200-day moving average. The market capitalization of the company currently stands at $55.89M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
On April 30, 2024, B. Riley Securities recently initiated its ‘Buy’ rating on the stock quoting a target price of $9, while ‘H.C. Wainwright’ rates the stock as ‘Buy’
In other news, LEVIN JEREMY M, CEO bought 18,248 shares of the company’s stock on Mar 18 ’24. The stock was bought for $50,364 at an average price of $2.76. Upon completion of the transaction, the CEO now directly owns 3,616,715 shares in the company, valued at $2.86 million. A total of 18.85% of the company’s stock is owned by insiders.
During the past 12 months, Ovid Therapeutics Inc has had a low of $0.75 and a high of $4.14. As of last week, the company has a debt-to-equity ratio of 0.58, a current ratio of 10.47, and a quick ratio of 10.47. The fifty day moving average price for OVID is $3.02846 and a two-hundred day moving average price translates $3.317965 for the stock.
The latest earnings results from Ovid Therapeutics Inc (NASDAQ: OVID) was released for 2024-03-31. The net profit margin was -10701.82% and return on equity was -50.87% for OVID. The company reported revenue of $0.15 million for the quarter, compared to $66000.0 a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 124.24 percent.
